Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.

Abstract

Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding feasibility, safety and perioperative outcome of these often complex procedures is limited.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer6
ISSN0748-7983
StatusVeröffentlicht - 2010
pubmed 20488646